Cargando…
Inhibiting the P2X4 Receptor Suppresses Prostate Cancer Growth In Vitro and In Vivo, Suggesting a Potential Clinical Target
Prostate cancer (PCa) is the most frequently diagnosed cancer in men, causing considerable morbidity and mortality. The P2X4 receptor (P2X4R) is the most ubiquitously expressed P2X receptor in mammals and is positively associated with tumorigenesis in many cancer types. However, its involvement in P...
Autores principales: | He, Jiepei, Zhou, Yuhan, Arredondo Carrera, Hector M., Sprules, Alexandria, Neagu, Ramona, Zarkesh, Sayyed Amin, Eaton, Colby, Luo, Jian, Gartland, Alison, Wang, Ning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699771/ https://www.ncbi.nlm.nih.gov/pubmed/33233569 http://dx.doi.org/10.3390/cells9112511 |
Ejemplares similares
-
C‐terminal variants of the P2X7 receptor are associated with prostate cancer progression and bone metastasis – evidence from clinical and pre‐clinical data
por: Song, Haiping, et al.
Publicado: (2022) -
PTH(1–34) treatment and/or mechanical loading have different osteogenic effects on the trabecular and cortical bone in the ovariectomized C57BL/6 mouse
por: Roberts, Bryant C., et al.
Publicado: (2020) -
P2Y Receptors in Bone - Anabolic, Catabolic, or Both?
por: Zhou, Yuhan, et al.
Publicado: (2022) -
P2X7 receptor regulates osteoclast function and bone loss in a mouse model of osteoporosis
por: Wang, Ning, et al.
Publicado: (2018) -
Optimization of production of recombinant human growth hormone in Escherichia coli
por: Rezaei, Marzieh, et al.
Publicado: (2012)